13-24690412-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001676.7(ATP12A):c.621G>C(p.Glu207Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001676.7 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP12A | ENST00000381946.5 | c.621G>C | p.Glu207Asp | missense_variant | Exon 6 of 23 | 1 | NM_001676.7 | ENSP00000371372.3 | ||
ATP12A | ENST00000218548.10 | c.621G>C | p.Glu207Asp | missense_variant | Exon 6 of 23 | 1 | ENSP00000218548.6 | |||
ENSG00000285806 | ENST00000782956.1 | n.281-1324C>G | intron_variant | Intron 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151556Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251480 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461878Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727244 show subpopulations
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151556Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 73924 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.621G>C (p.E207D) alteration is located in exon 6 (coding exon 6) of the ATP12A gene. This alteration results from a G to C substitution at nucleotide position 621, causing the glutamic acid (E) at amino acid position 207 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at